Clinical Trials Directory

Trials / Completed

CompletedNCT01332253

Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Trial of the Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
161 (actual)
Sponsor
Cumberland Pharmaceuticals · Industry
Sex
All
Age
6 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The hypothesis is that a single, pre-operative dose of intravenous ibuprofen will significantly reduce post-operative fentanyl use compared to placebo.

Conditions

Interventions

TypeNameDescription
DRUGIntravenous ibuprofenParticipants will receive a single 10mg/kg dose of intravenous ibuprofen diluted in normal saline at the induction of anesthesia.
OTHERNormal SalineParticipants will receive a comparable weight based volume of normal saline as a placebo comparator at the induction of anesthesia.

Timeline

Start date
2011-07-01
Primary completion
2012-07-01
Completion
2012-08-01
First posted
2011-04-11
Last updated
2016-11-03
Results posted
2016-11-03

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01332253. Inclusion in this directory is not an endorsement.

Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy (NCT01332253) · Clinical Trials Directory